Grifols/ Biomat USA Company Information

Profile:

Grifols has been a leader in the healthcare industry since 1940 by creating innovative products and services based on the values of ethics, quality and responsibility. Grifols' activities focus on fulfilling the needs of its patients as well as healthcare professionals working in therapeutics, pharmacy, diagnostics and blood banking. For more than 60 years, Grifols has developed, manufactured and marketed products designed to improve human health. At its Los Angeles facility, Grifols manufactures plasma derived biopharmaceutical products of proven efficacy, quality and safety.

Since 2001 , Grifols has acquired 80 plasmapheresis donor centers within the USA. The donor centers derived from the following companies: Biomat USA, Inc. with 60 donor centers, Plasma Collection Centers, Inc., (PCCI) with 4 donor centers and Plasmacare, Inc. with 16 donor centers. These state of the art facilities collect human plasma from paid donors to create life-saving pharmaceutical products such as clotting factors, immunoglobulin and albumin for patients who suffer from bleeding disorders, immune system deficiencies, burns and shock.